A Downside Of Pandemic Preparedness: Wall Street May Not Value Government Contracts
Executive Summary
Human Genome Sciences founder William Haseltine says company's stock did not move following BARDA contract for its anthrax treatment; advises industry to forget about IP for COVID-19 products.